University of Pittsburgh Reports Successful COVID-19 Vaccine Trial
Share
[aggregation-styles]
Meadville Tribune
PITTSBURGH – Researchers at the University of Pittsburgh School of Medicine report initial success in animal trials for a vaccine to neutralize the virus that causes COVID-19.
During tests in mice, the vaccine was shown to produce antibodies specific to SARS-CoV-2, known as the novel coronavirus. University researchers said the mice responded with antibodies sufficient to neutralize the virus.
The researchers released their findings today in a paper published in EBioMedicine, published by The Lancet, a leading British medical journal.
The authors said they are now in the process of seeking investigatory new drug approval from the U.S. Food and Drug Administration with expectation of beginning human clinical trial within the next few months.
Read More →
Meadville Tribune
PITTSBURGH – Researchers at the University of Pittsburgh School of Medicine report initial success in animal trials for a vaccine to neutralize the virus that causes COVID-19.
During tests in mice, the vaccine was shown to produce antibodies specific to SARS-CoV-2, known as the novel coronavirus. University researchers said the mice responded with antibodies sufficient to neutralize the virus.
The researchers released their findings today in a paper published in EBioMedicine, published by The Lancet, a leading British medical journal.
The authors said they are now in the process of seeking investigatory new drug approval from the U.S. Food and Drug Administration with expectation of beginning human clinical trial within the next few months.
Read More →
RELATED TOPICS:
Categories
Latest
Videos
Science /
14 hours ago
Trump Has Cut Science Funding to Its Lowest Level in Decades
Courts /
14 hours ago
Judge Bars Trump Administration From Detaining Mahmoud Khalil
Business /
14 hours ago
